166 related articles for article (PubMed ID: 17822507)
1. Trichostasis spinulosa: possible association with prolonged topical application of clobetasol propionate 0.05% cream.
Janjua SA; McKoy KC; Iftikhar N
Int J Dermatol; 2007 Sep; 46(9):982-5. PubMed ID: 17822507
[No Abstract] [Full Text] [Related]
2. In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.
Gans EH; Sadiq I; Stoudemayer T; Stoudemayer M; Kligman AM
J Drugs Dermatol; 2008 Jan; 7(1):28-32. PubMed ID: 18246695
[TBL] [Abstract][Full Text] [Related]
3. Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent.
Tobin AM; Barragry J; Kirby B; O'Shea L
Ir Med J; 2005 Apr; 98(4):118. PubMed ID: 15938560
[No Abstract] [Full Text] [Related]
4. The comparison of treatment with clobetasol propionate 0.05% and topical pimecrolimus 1% treatment in the treatment of alopecia areata.
Ucak H; Kandi B; Cicek D; Halisdemir N; Dertlıoğlu SB
J Dermatolog Treat; 2012 Dec; 23(6):410-20. PubMed ID: 21787210
[TBL] [Abstract][Full Text] [Related]
5. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: a double-blind study.
Rigopoulos D; Gregoriou S; Katsambas A
Acta Derm Venereol; 2007; 87(2):167-8. PubMed ID: 17340027
[No Abstract] [Full Text] [Related]
6. Adult iatrogenic Cushing's syndrome induced by topical skin corticosteroid misuse.
Negrini S; Murdaca G; Ferone D; Borro M
Therapie; 2019 Oct; 74(5):547-549. PubMed ID: 31023618
[No Abstract] [Full Text] [Related]
7. Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB.
Fetil E; Ilknur T; Altiner D; Ozkan S; Güneş AT
J Dermatol; 2005 Nov; 32(11):868-74. PubMed ID: 16361746
[TBL] [Abstract][Full Text] [Related]
8. Irrational use of skin-bleaching products can delay the diagnosis of leprosy.
Mahé A; Ly F; Badiane C; Baldé Y; Dangou JM
Int J Lepr Other Mycobact Dis; 2002 Jun; 70(2):119-21. PubMed ID: 12211896
[No Abstract] [Full Text] [Related]
9. Excimer laser vs. clobetasol propionate 0·05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot.
Brenninkmeijer EE; Spuls PI; Lindeboom R; van der Wal AC; Bos JD; Wolkerstorfer A
Br J Dermatol; 2010 Oct; 163(4):823-31. PubMed ID: 20491772
[TBL] [Abstract][Full Text] [Related]
10. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
Faghihi G; Iraji F; Shahingohar A; Saidat A
J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.
Lee CS; Koo J
J Drugs Dermatol; 2009 Aug; 8(8):751-5. PubMed ID: 19663113
[TBL] [Abstract][Full Text] [Related]
13. Topical clobetasol propionate treatment and cutaneous adverse effects in patients with early-stage mycosis fungoides: an observational study.
Geller S; Myskowski PL
Cutis; 2020 May; 105(5):E27-E32. PubMed ID: 32603400
[TBL] [Abstract][Full Text] [Related]
14. Coexistence of trichostasis spinulosa and eruptive vellus hair cysts.
Lazarov A; Amichai B; Cagnano M; Halevy S
Int J Dermatol; 1994 Dec; 33(12):858-9. PubMed ID: 7883410
[No Abstract] [Full Text] [Related]
15. Topical clobetasol in conjunction with topical tretinoin is effective in preventing scar formation after superficial partial-thickness burn ulcers of the skin: A retrospective study.
Taheri A; Moradi Tuchayi S; Alinia H; Orscheln CS; Mansoori P; Feldman SR
J Dermatolog Treat; 2015; 26(4):361-4. PubMed ID: 25424054
[TBL] [Abstract][Full Text] [Related]
16. Two cases of Cushing's syndrome due to overuse of topical steroid in the diaper area.
Semiz S; Balci YI; Ergin S; Candemir M; Polat A
Pediatr Dermatol; 2008; 25(5):544-7. PubMed ID: 18950396
[TBL] [Abstract][Full Text] [Related]
17. Sequelae from inadvertent long-term use of potent topical steroids.
Beer K; Downie J
J Drugs Dermatol; 2007 May; 6(5):550-1. PubMed ID: 17679193
[TBL] [Abstract][Full Text] [Related]
18. An infantile Cushing syndrome due to misuse of topical steroid.
Siklar Z; Bostanci I; Atli O; Dallar Y
Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
[TBL] [Abstract][Full Text] [Related]
19. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
Cherian MP; AbdulJabbar M
Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195
[No Abstract] [Full Text] [Related]
20. Treating umbilical granuloma with topical clobetasol propionate cream at home is as effective as treating it with topical silver nitrate in the clinic.
Brødsgaard A; Nielsen T; Mølgaard U; Pryds O; Pedersen P
Acta Paediatr; 2015 Feb; 104(2):174-7. PubMed ID: 25297721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
